Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PDS Biotechnology Corp | 54,876 | reported | 12 Jan 2026 | tx 9+137,373 |
| RIGEL PHARMACEUTICALS INC | 12,625 | reported | 26 May 2026 | tx 11+282,500−2,500 |
| Aclaris Therapeutics, Inc. | 0 | reported | 03 Jan 2022 | tx 114+921,527−449,084 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 May 2026 | SALE | RIGEL PHARMACEUTICALS INC | 2,500 | 29.17 USD | 10b5-1 |
| 15 May 2026 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 5,750 | 0.00 USD | |
| 12 Jan 2026 | GRANT_AWARD | PDS Biotechnology Corp | 54,876 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | PDS Biotechnology Corp | 22,700 | 0.00 USD | deriv |
| 23 May 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 2,500 | 0.00 USD | |
| 23 May 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 3,000 | 0.00 USD | deriv |
| 24 Jun 2024 | GRANT_AWARD | PDS Biotechnology Corp | 9,000 | 0.00 USD | deriv |
| 25 May 2024 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 25,000 | 0.00 USD | |
| 25 May 2024 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 14 Jul 2023 | GRANT_AWARD | PDS Biotechnology Corp | 9,000 | 0.00 USD | deriv |
| 26 May 2023 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 25,000 | 0.00 USD | |
| 26 May 2023 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 28 Jun 2022 | GRANT_AWARD | PDS Biotechnology Corp | 9,000 | 0.00 USD | deriv |
| 20 May 2022 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 18,750 | 0.00 USD | |
| 20 May 2022 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 22,500 | 0.00 USD | deriv |
| 03 Jan 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 3,875 | — | |
| 03 Jan 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 6,638 | — | |
| 03 Jan 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 27,905 | — | |
| 03 Jan 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 7,100 | — | |
| 03 Jan 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 6,638 | 0.00 USD | deriv |
| 03 Jan 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 27,905 | 0.00 USD | deriv |
| 03 Jan 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 7,100 | 0.00 USD | deriv |
| 03 Jan 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 3,875 | 0.00 USD | deriv |
| 16 Dec 2021 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 120,000 | 0.00 USD | deriv |
| 11 Mar 2021 | GIFT | Aclaris Therapeutics, Inc. | 7,500 | 0.00 USD |